covid-19 |
45 |
public health |
26 |
stroke |
26 |
type 2 diabetes mellitus |
26 |
dementia |
20 |
myocardial infarction |
20 |
coronary artery disease |
19 |
medical sciences |
17 |
healthcare workers |
16 |
hospital policies |
16 |
perceived stress |
16 |
psychological wellbeing |
16 |
hypertension |
15 |
ischemic stroke |
15 |
risk prediction |
15 |
atrial fibrillation |
14 |
complications |
14 |
coronavirus infection |
14 |
health outcomes |
14 |
sars-cov-2 |
14 |
blood pressure |
13 |
intracerebral hemorrhage |
13 |
chronic diseases |
12 |
health services |
12 |
non-communicable diseases |
12 |
health economics |
11 |
intracranial hemorrhage |
11 |
primary care |
11 |
risk factor |
11 |
secondary prevention |
11 |
adipocyte |
10 |
adverse events |
10 |
b-type natriuretic peptide |
10 |
blood pressure variability |
10 |
cardiac troponin |
10 |
covid-19 vaccine |
10 |
delirium |
10 |
fibroblast growth factor |
10 |
lipocalin-2 |
10 |
vaccine safety |
10 |
carotid intima-media thickness |
9 |
endothelial function |
9 |
female |
9 |
garlic |
9 |
humans |
9 |
male |
9 |
recurrence |
9 |
vascular function |
9 |
aerosolised |
8 |
anosmia |
8 |
cardiovascular and cerebrovascular diseases |
8 |
cha2ds2-vasc |
8 |
chads2 |
8 |
endothelial dysfunction |
8 |
endothelial progenitor cells |
8 |
follow-up studies |
8 |
functional brain network |
8 |
hemoglobin a1c |
8 |
indirect effect |
8 |
long covid |
8 |
meta-analysis |
8 |
middle aged |
8 |
mortality |
8 |
olfactory dysfunction |
8 |
olfactory training |
8 |
prognosis |
8 |
resting-state fmri |
8 |
risk factors |
8 |
smell loss |
8 |
systematic review |
8 |
vascular markers |
8 |
vascular markers of atherosclerosis |
8 |
vitamin a |
8 |
warfarin |
8 |
25-hydroxyvitamin d |
7 |
antiplatelet medication |
7 |
cha2ds2-vasc score |
7 |
chads2 score |
7 |
circulating endothelial progenitor cells |
7 |
covid-19 pandemic |
7 |
cutoff |
7 |
epidemiology |
7 |
hematoma location |
7 |
hong kong |
7 |
intracranial hemorrhages |
7 |
isoflavone |
7 |
lacunar infarct |
7 |
physical activity |
7 |
pleiotropic effects |
7 |
pr prolongation |
7 |
school closures |
7 |
school-aged children |
7 |
screen time |
7 |
sleep |
7 |
statin therapy |
7 |
stroke outcome |
7 |
adverse cardiovascular events |
6 |
adverse cardiovascular outcomes |
6 |
age factors |
6 |
aged |
6 |
alff |
6 |
antiplatelet agents |
6 |
arterial stiffiness |
6 |
aspirin - administration & dosage - adverse effects |
6 |
atrioventricular block - complications - diagnosis - physiopathology |
6 |
brachial artery - physiopathology - ultrasonography |
6 |
cardiovascular continuum |
6 |
cardiovascular death |
6 |
cardiovascular diseases - blood - diet therapy - prevention & control |
6 |
cardiovascular diseases - etiology - physiopathology |
6 |
cardiovascular event |
6 |
cerebral small vessel disease |
6 |
cerebrovascular event |
6 |
chads2 and cha2ds2-vasc scores |
6 |
chronic kidney disease |
6 |
data repository |
6 |
diet |
6 |
dietary supplements |
6 |
diffusivity |
6 |
dti |
6 |
electrocardiography |
6 |
endothelial cells - cytology - physiology |
6 |
endothelium, vascular - cytology - physiology |
6 |
flow cytometry |
6 |
functional connectivity |
6 |
functional mri |
6 |
has-bled score |
6 |
high-sensitivity troponin i |
6 |
ich volume |
6 |
intracranial hemorrhages - drug therapy - physiopathology - surgery |
6 |
intraventricular extension |
6 |
mediterranean-style diet |
6 |
meta-data |
6 |
multimodal |
6 |
myocardial injury |
6 |
neurogen |
6 |
neurological and mental health global epidemiology network |
6 |
neurological deterioration |
6 |
parkinson's disease |
6 |
pathophysiological mechanism |
6 |
phytoestrogen |
6 |
phytoestrogens - administration & dosage |
6 |
platelet aggregation inhibitors - administration & dosage - adverse effects |
6 |
pr interval prolongation |
6 |
questionnaires |
6 |
recurrent stroke |
6 |
registries |
6 |
resting state |
6 |
retrospective studies |
6 |
spondyloarthritis |
6 |
stem cells - physiology |
6 |
stroke/prevention |
6 |
treatment outcome |
6 |
vascular dysfunction |
6 |
vasodilation |
6 |
visit-to-visit blood pressure variability |
6 |
visual hallucinations |
6 |
visual spatial memory |
6 |
warfarin-associated ich |
6 |
antigens, cd34 - analysis |
5 |
arteriosclerosis - etiology - pathology - ultrasonography |
5 |
autoimmune encephalitis |
5 |
brachial artery - drug effects - physiology |
5 |
c-reactive protein |
5 |
c-reactive protein - metabolism |
5 |
carotid arteries - pathology - ultrasonography |
5 |
case-control studies |
5 |
cell count |
5 |
cerebral microbleed |
5 |
cognitive footprints |
5 |
donepezil |
5 |
electronic medical records |
5 |
endothelial cells - pathology |
5 |
endothelium, vascular - drug effects |
5 |
endothelium, vascular - pathology - ultrastructure |
5 |
follow-up |
5 |
isoflavones - administration and dosage - therapeutic use |
5 |
limbic encephalitis |
5 |
machine learning |
5 |
magnetic |
5 |
memantine |
5 |
optic neuritis |
5 |
paraneoplastic syndrome |
5 |
renal impairment |
5 |
resonance imaging |
5 |
rivastigmine |
5 |
soybean proteins - therapeutic use |
5 |
stem cells - pathology |
5 |
stroke - pathology |
5 |
survivors |
5 |
tunica intima - ultrasonography |
5 |
tunica media - ultrasonography |
5 |
acquired myasthenia gravis |
4 |
adult cardiology |
4 |
alzheimer’s disease |
4 |
analysis of variance |
4 |
antidepressants |
4 |
aquaporin-4 autoantibodies |
4 |
atherosclerosis |
4 |
autoimmune |
4 |
azathioprine |
4 |
blood flow velocity |
4 |
blood pressure - drug effects - physiology |
4 |
brachial artery - pathology |
4 |
cardiovascular diseases - blood - diagnosis - mortality |
4 |
cardiovascular diseases - epidemiology - metabolism |
4 |
caregiver burden |
4 |
caregivers |
4 |
carotid arteries - pathology |
4 |
causal associations |
4 |
classical multiple sclerosis |
4 |
clinical outcome |
4 |
coronary artery disease - pathology |
4 |
coronavirus disease |
4 |
diabetes mellitus, type 2 - blood - diagnosis - mortality |
4 |
diet surveys |
4 |
endothelium, vascular - drug effects - physiology |
4 |
family caregivers |
4 |
family functioning |
4 |
flow-mediated dilation |
4 |
high-sensitivity troponin i outcome |
4 |
immunosuppressant therapy |
4 |
incidence |
4 |
inflammatory demyelinating disorders |
4 |
isoflavones - administration & dosage |
4 |
lipid metabolism - drug effects - physiology |
4 |
low‐density lipoprotein cholesterol |
4 |
neuromyelitis optica spectrum disorders |
4 |
pandemic |
4 |
prospective cohort study |
4 |
psychiatry and neurology |
4 |
qualitative research |
4 |
randomized controlled trial |
4 |
self-controlled case series studies |
4 |
soybean proteins - administration & dosage |
4 |
soybeans - chemistry |
4 |
stroke rehabilitation |
4 |
stroke survivors |
4 |
telemedicine |
4 |
troponin i - blood |
4 |
tunica intima - pathology |
4 |
tunica intima - pathology - ultrasonography |
4 |
tunica media - pathology - ultrasonography |
4 |
two-tier family-oriented intervention |
4 |
ankle brachial index |
3 |
cerebral microbleeds |
3 |
cyclegan |
3 |
deep learning |
3 |
encephalitis |
3 |
flow-mediated dilatation |
3 |
nervous system |
3 |
pulse wave velocity |
3 |
quantitative susceptibility mapping |
3 |
resnet |
3 |
surrogate marker |
3 |
transient ischemic attack |
3 |
v-net |
3 |
angioplasty |
2 |
aquaporin 4 |
2 |
atherosclerosis. |
2 |
autoimmunity |
2 |
cardiovascular system - diseases. |
2 |
cognitive impairment |
2 |
diffusion-weighted imaging |
2 |
direct oral anticoagulants |
2 |
ectopic lymphoid structures |
2 |
functional prediction |
2 |
germinal center |
2 |
magnetic resonance imaging |
2 |
neuroimaging |
2 |
neuromyelitis optica spectrum disorder |
2 |
oral anticoagulant |
2 |
perivascular spaces |
2 |
prevalence |
2 |
prospective studies |
2 |
rich-club organization |
2 |
small vessel disease |
2 |
stroke recovery |
2 |
strokebleeding |
2 |
structural network |
2 |
thrombectomy |
2 |
vascular dementia |
2 |
adenocarcinoma - diagnosis - secondary |
1 |
adolescent |
1 |
adult |
1 |
blood biomarkers |
1 |
brain atherosclerosis |
1 |
brain hemorrhage |
1 |
brain ischemia |
1 |
carotid pulsatility |
1 |
causal inference |
1 |
cerebrovascular accident |
1 |
cerebrovascular disease |
1 |
child |
1 |
functional recovery |
1 |
hemorrhagic stroke |
1 |
ischemic attack, transient - diagnosis |
1 |
ischemic attack, transient - therapy |
1 |
mean corpuscular volume |
1 |
mendelian randomization |
1 |
middle cerebral artery |
1 |
molecular biomarkers |
1 |
multimodal biomarkers |
1 |
muscle neoplasms - diagnosis - secondary |
1 |
muscle, skeletal |
1 |
neurophysiology |
1 |
pathologic constriction |
1 |
red blood cell distribution width |
1 |
stroke - diagnosis |
1 |
stroke - therapy |
1 |
tomography, x-ray computed |
1 |